Edition:
United States

aTyr Pharma Inc (LIFE.O)

LIFE.O on Nasdaq

4.00USD
8 Dec 2017
Change (% chg)

$0.10 (+2.56%)
Prev Close
$3.90
Open
$3.90
Day's High
$4.05
Day's Low
$3.80
Volume
36,243
Avg. Vol
90,388
52-wk High
$6.50
52-wk Low
$2.10

Chart for

About

aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based... (more)

Overall

Beta: --
Market Cap(Mil.): $119.03
Shares Outstanding(Mil.): 29.76
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 186.11 15.67
EPS (TTM): -- -- --
ROI: -- -11.32 34.62
ROE: -- -35.69 16.00

BRIEF-aTyr Pharma reports qtrly ‍net loss per share, basic and diluted $0.43​

* aTyr Pharma announces third quarter 2017 operating results and provides corporate update

Nov 14 2017

BRIEF-Atyr Pharma files for resale of up to 23.6 mln shares of common stock by selling stockholders - SEC Filing‍​

* Atyr Pharma Inc files for resale of up to 23.6 million shares of common stock by selling stockholders - SEC Filing‍​ Source text: [http://bit.ly/2h4V7rA] Further company coverage:

Sep 14 2017

BRIEF-‍Viking Global Investors reports 9.5 pct passive stake in aTyr Pharma​

* ‍Viking Global Investors Lp reports 9.5 percent passive stake in aTyr Pharma Inc as on August 31, 2017 - SEC filing​ Source text : (http://bit.ly/2vP2d66) Further company coverage:

Sep 11 2017

BRIEF-Atyr Pharma qtrly ‍net loss per share $0.51​

* Atyr Pharma announces second quarter 2017 operating results and provides an update on innovative immunology pipeline

Aug 14 2017

BRIEF-ATyr pharma enters into first amendment to loan and security agreement

* ATyr Pharma says on june 30, entered into first amendment to loan and security agreement with silicon valley bank and solar capital ltd - SEC filing

Jul 05 2017

Earnings vs. Estimates